New A-ring analogs of the hormone 1α,25-dihydroxyvitamin D3: (2′-hydroxymethyl)tetrahydrofuro[1,2-a]-25-hydroxyvitamin D3

Tetrahedron

Volumn 65, Issue 7, 2009, Pages 1235-1240

  Jeon, Heung Bae ^a,b   Posner, Gary H ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Kwangwoon University   (South Korea)

Author keywords

A Ring modified analogs; Bicyclic A ring phosphine oxide; Lythgoe type coupling; Vitamin D3 analogs

Indexed keywords

(2' HYDROXYMETHYL)TETRAHYDROFURO[1,2 ALPHA] 25 HYDROXYVITAMIN D3; CALCITRIOL DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; FURAN DERIVATIVE; KETONE DERIVATIVE; PHOSPHINE OXIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBONYLATION; CELL PROLIFERATION; CHEMICAL REACTION; DIELS ALDER REACTION; DRUG EFFECT; DRUG SYNTHESIS; ENANTIOSELECTIVITY; IN VITRO STUDY; ISOMER; PRIORITY JOURNAL; SILYLATION;

EID: 58149343247     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2008.12.034     Document Type: Article

References (37)

1. Yamada S., Shimizu M., and Yamamoto K. Med. Res. Rev. 23 (2003) 89-115
2. Brown A.J., Dusso A., and Slatopolsky E. Am. J. Physiol. 277 (1999) F157-F175
3. Bouillon R., Okamura W.H., and Norman A.W. Endocr. Rev. 16 (1995) 200-257
4. Posner G.H., and Kahraman M. Eur. J. Org. Chem. (2003) 3889-3895
5. Petersen K.S., Dolan P.M., Kensler T.W., Peleg S., and Posner G.H. J. Med. Chem. 50 (2007) 5824-5832
6. Usera A.R., Dolan P.M., Kensler T.W., and Posner G.H. Bioorg. Med. Chem. 15 (2007) 5509-5518
7. Sinishtaj S., Jeon H.B., Dolan P.M., Kensler T.W., and Posner G.H. Bioorg. Med. Chem. 14 (2006) 6341-6348
8. Posner G.H., Kim H.J., Kahraman M., Jeon H.B., Suh B.C., Li H., Dolan P.M., and Kensler T.W. Bioorg. Med. Chem. 13 (2005) 5569-5580
9. Kahraman M., Sinishtaj S., Dolan P.M., Kensler T.W., Peleg S., Saha U., Chuang S.S., Bernstein G., Korczak B., and Posner G.H. J. Med. Chem. 47 (2004) 6854-6863
10. Suh B.-C., Jeon H.B., Posner G.H., and Silverman S.M. Tetrahedron Lett. 45 (2004) 4623-4626
11. Sussman F., Rumbo A., Vilaverde M.C., and Mourino A. J. Med. Chem. 47 (2004) 1613-1616
12. Posner G.H., Halford B.A., Peleg S., Dolan P., and Kensler T.W. J. Med. Chem. 45 (2002) 1723-1730
13. Posner G.H., Crawford K., Siu-Caldera M.-L., Reddy G.S., Sarabia S.F., Feldman D., van Etten E., Mathieu C., Gennaro L., Vouros P., Peleg S., Dolan P.M., and Kensler T.W. J. Med. Chem. 43 (2000) 3581-3586
14. Posner G.H., Wang Q., Han G., Lee J.K., Crawford K., Zand S., Berm H., Peleg S., Dolan P., and Kensler T.W. J. Med. Chem. 42 (1999) 3425-3435
15. Yamada S., Yamamoto K., Masuno H., and Ohta M. J. Med. Chem. 41 (1998) 1467-1475
16. Saito N., Honzawa S., and Kittaka A. Curr. Top. Med. Chem. 6 (2006) 1273-1288
17. Peleg S., Petersen K.S., Suh B.C., Dolan P., Agoston E.S., Kensler T.W., and Posner G.H. J. Med. Chem. 49 (2006) 7513-7517
18. Hatcher M.A., Peleg S., Dolan P., Kensler T.W., Sarjeant A., and Posner G.H. Bioorg. Med. Chem. 13 (2005) 3964-3976
19. Sicinska W., Rotkiewicz P., and DeLuca H.F. J. Steroid Biochem. Mol. Biol. 89 (2004) 107-110
20. Sicinski R.R., Rotkiewicz P., Kolinski A., Sicinska W., Prahl J.M., Smith C.M., and DeLuca H.F. J. Med. Chem. 45 (2002) 3366-3380
21. Hilpert H., and Wirz B. Tetrahedron 57 (2001) 681-694
22. Zhou X., Zhu G.-D., Van Haver D., Vandewalle M., DeClercq P.J., Verstuyf A., and Bouillon R. J. Med. Chem. 42 (1999) 3539-3556
23. Sicinski R.R., Prahl J.M., Smith C.M., and DeLuca H.F. J. Med. Chem. 41 (1998) 4662-4674
24. Posner G.H., Nelson T.D., Guyton K.Z., and Kensler T.W. J. Med. Chem. 35 (1992) 3280-3287
25. Perlman K.L., Swenson R.E., Paaren H.E., Schnoes H.K., and DeLuca H.F. Tetrahedron Lett. 32 (1991) 7663-7666
26. Rochel N., Wurtz J.M., Mitschler A., Klaholz B., and Moras D. Mol. Cell 5 (2000) 173-179
27. Matsumoto T., Miki T., Hagino H., Sugimoto T., Okamoto S., Hirata T., Yanagisawa Y., Hayashi Y., Fukunaga M., Shiraki M., and Nakamura T. J. Clin. Endocrinol. Metab. 90 (2005) 5031-5036
28. Miyamoto K., Murayama E., Ochi K., Watanabe H., and Kubodera N. Chem. Pharm. Bull. 41 (1993) 1111-1113
29. Nagasawa K., Matsuda N., Noguchi Y., Yamanashi M., Zako Y., and Shimizu I. J. Org. Chem. 58 (1993) 1483-1490
30. Baggiolini E.G., Iacobelli J.A., Hennessy B.M., Batcho A.D., Sereno J.F., and Uskokovic M.R. J. Org. Chem. 51 (1986) 3098-3108
31. Takle A., and Kocienski P. Tetrahedron 46 (1990) 4503-4516
32. Mandai T., Imaji M., Takada H., Kawata M., Nokami J., and Tsuji J. J. Org. Chem. 54 (1989) 5395-5397
33. 1H NMR showed a trans, trans, cis coupling constant of ddd (J=12.4, 8.4, 4.4 Hz) pattern. From this fact, it was concluded that product (-)-12 was generated from the cycloadduct 8a. In addition, the other intermediates shown in Schemes 2 and 3 also showed that the coupling constant of H at C3 matched with the trans, trans, cis type. In case of (+)-9, although its stereochemistry was not clear at first, the same compound (-)-12 with the same physical data after several reaction steps was obtained.{A figure is presented}
34. Zhang W., Loebach J.L., Wilson S.R., and Jacobsen E.N. J. Am. Chem. Soc. 112 (1990) 2801-2803
35. Noguchi Y., Yamada T., Uchiro H., and Kobayashi S. Tetrahedron Lett. 41 (2000) 7493-7497
36. Posner G.H., Crouch R.D., Kinter C.M., and Carry J.-C. J. Org. Chem. 56 (1991) 6981-6987
37. Lythgoe B., Moran T.A., Nambudiry M.E.N., Tideswell J., and Wright P.W. J. Chem. Soc., Perkin Trans. 1 (1978) 590-595